| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 763657 | 89112 | TICAGRELOR KERN PHARMA 60 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | TICAGRELOR KERN PHARMA 60 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 60 comprimidos | 60 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89112/89112_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89112/89112_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2023-10-31 | 1 | 1 | 1 | 2023-11-01 | 2023-10-31 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 763674 | 89120 | TICAGRELOR KERN PHARMA 90 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | TICAGRELOR KERN PHARMA 90 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 56 comprimidos | 90 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89120/89120_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89120/89120_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2023-10-31 | 1 | 1 | 1 | 2023-11-01 | 2023-10-31 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 764277 | 89331 | MEMANTINA KERN PHARMA 5 MG + 10 MG + 15 MG + 20 MG COMPRIMIDOS EFG | MEMANTINA KERN PHARMA 5 MG + 10 MG + 15 MG + 20 MG COMPRIMIDOS EFG, 28 comprimidos (7x5 mg, 7x10 mg, 7x15 mg, 7x20 mg) | 5 mg + 10 mg + 15 mg + 20 mg | 5 | 28 | 10 | 28 comprimidos (7x5 mg, 7x10 mg, 7x15 mg, 7x20 mg) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89331/89331_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89331/89331_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-05-13 | View Edit Delete | ||||||||||||
| 764304 | 89341 | TERIFLUNOMIDA KERN PHARMA 14 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | TERIFLUNOMIDA KERN PHARMA 14 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos (PVC/PCTFE/Al) | 14 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PCTFE/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89341/89341_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89341/89341_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2024-02-13 | 1 | 1 | 1 | 2024-02-14 | 2024-02-13 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764321 | 89352 | REVISEA 80 MG CÁPSULAS BLANDAS | REVISEA 80 MG CÁPSULAS BLANDAS, 30 cápsulas | 80 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89352/89352_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89352/89352_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1534 | KERN PHARMA S.L. | 2024-02-15 | 1 | 1 | 1 | 2024-02-16 | 2024-02-15 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 763735 | 89150 | TOSHEDRA 7 MG/ML JARABE | TOSHEDRA 7 MG/ML JARABE, 150 ml | 7 mg/ml | 6 | 150 | 26 | 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89150/89150_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89150/89150_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 763737 | 89151 | TOSHEDRA 35 MG JARABE EN SOBRES | TOSHEDRA 35 MG JARABE EN SOBRES, 20 sobres de 5 ml | 35 mg | 35 | 20 | 64 | 20 sobres de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89151/89151_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89151/89151_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 764645 | 78556 | METOCLOPRAMIDA KERN PHARMA 5 MG/ML SOLUCION INYECTABLE EFG | METOCLOPRAMIDA KERN PHARMA 5 MG/ML SOLUCION INYECTABLE EFG, 6 ampollas de 2 ml | 10 mg inyectable 2 ml | 1 | 6 | 1 | 6 ampollas de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78556/78556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78556/78556_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2014-03-12 | 1 | 1 | 1 | 2014-03-12 | 2024-04-01 | 1 | 2024-09-12 | View Edit Delete | ||||||||||||
| 765382 | 89698 | TAMSULOSINA KERN PHARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA KERN PHARMA 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89698/89698_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89698/89698_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2024-07-12 | 1 | 1 | 1 | 2024-07-13 | 2024-07-12 | 1 | 2025-03-14 | View Edit Delete | ||||||||||||
| 764795 | 89519 | TUSSAL 35,4 MG JARABE EN SOBRES | TUSSAL 35,4 MG JARABE EN SOBRES, 20 sobres de 10 ml | 35,4 mg | 35 | 20 | 64 | 20 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89519/89519_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89519/89519_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2024-04-25 | 1 | 1 | 1 | 2024-04-26 | 2024-04-25 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 766532 | 90038 | ACETILCISTEINA KERN PHARMA 100 MG/ML SOLUCION INYECTABLE EFG | ACETILCISTEINA KERN PHARMA 100 MG/ML SOLUCION INYECTABLE EFG, 5 ampollas de 3 ml | 300 mg inyectable 3 ml | 1 | 5 | 1 | 5 ampollas de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90038/90038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90038/90038_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2024-12-27 | 1 | 1 | 1 | 2024-12-28 | 2024-12-27 | 1 | 2025-03-14 | View Edit Delete | ||||||||||||
| 766947 | 41764 | FENTANEST 0,05 mg/ml SOLUCION INYECTABLE | FENTANEST 0,05 mg/ml SOLUCION INYECTABLE, 10 ampollas de 3 ml | 50 microgramos/ml inyectable 3 ml | 1 | 10 | 1 | 10 ampollas de 3 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41764/41764_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41764/41764_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1965-11-01 | 1 | 1 | 1 | 1965-11-01 | 2025-02-17 | 1 | 2026-06-11 | Lista I | View Edit Delete | |||||||||||
| 765682 | 89802 | ELTROMBOPAG KERN PHARMA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ELTROMBOPAG KERN PHARMA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos | 25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89802/89802_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89802/89802_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2024-09-06 | 1 | 1 | 1 | 2024-09-07 | 2024-09-06 | 1 | 2025-08-12 | View Edit Delete | ||||||||||||
| 765683 | 89803 | ELTROMBOPAG KERN PHARMA 50 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ELTROMBOPAG KERN PHARMA 50 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89803/89803_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89803/89803_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2024-09-06 | 1 | 1 | 1 | 2024-09-07 | 2024-09-06 | 1 | 2025-08-12 | View Edit Delete | ||||||||||||
| 765684 | 89804 | ELTROMBOPAG KERN PHARMA 75 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ELTROMBOPAG KERN PHARMA 75 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos | 75 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89804/89804_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89804/89804_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2024-09-06 | 1 | 1 | 1 | 2024-09-07 | 2024-09-06 | 1 | 2025-08-12 | View Edit Delete | ||||||||||||
| 766327 | 83864 | METFORMINA KERN PHARMA 850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | METFORMINA KERN PHARMA 850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 850 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83864/83864_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83864/83864_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2019-02-25 | 1 | 1 | 1 | 2019-02-26 | 2024-11-21 | 0 | 2025-02-14 | View Edit Delete | ||||||||||||
| 766764 | 65466 | AMLODIPINO KERN PHARMA 5 mg COMPRIMIDOS EFG | AMLODIPINO KERN PHARMA 5 mg COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65466/65466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65466/65466_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2003-06-30 | 1 | 1 | 1 | 2003-06-30 | 2025-01-28 | 1 | 2025-09-10 | View Edit Delete | ||||||||||||
| 766949 | 33488 | HALOPERIDOL PRODES 2mg/ml GOTAS ORALES EN SOLUCION | HALOPERIDOL PRODES 2mg/ml GOTAS ORALES EN SOLUCION , 1 frasco de 15 ml | 2 mg/ml | 6 | 15 | 26 | 1 frasco de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/33488/33488_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/33488/33488_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 1960-02-01 | 1 | 1 | 1 | 1960-02-01 | 1960-02-01 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 766455 | 83900 | DICLOKERN FORTE 23,2 MG/G GEL | DICLOKERN FORTE 23,2 MG/G GEL, 1 tubo de 150 g | 20 mg/g | 44 | 150 | 21 | 1 tubo de 150 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83900/83900_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83900/83900_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2019-03-05 | 1 | 1 | 1 | 2019-03-06 | 2024-12-13 | 1 | 2025-05-14 | View Edit Delete | ||||||||||||
| 768423 | 90554 | EZETIMIBA/ATORVASTATINA KERN PHARMA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EZETIMIBA/ATORVASTATINA KERN PHARMA 10 MG/20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 20 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90554/90554_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90554/90554_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2025-09-05 | 1 | 1 | 1 | 2025-09-06 | 2025-09-05 | 1 | 2026-03-12 | View Edit Delete |
Page 183 of 1036, showing 20 records out of 20709 total, starting on record 3641, ending on 3660